{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T22:16:57Z","timestamp":1765232217178},"reference-count":4,"publisher":"Medwave Estudios Limitada","issue":"02","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medwave"],"DOI":"10.5867\/medwave.2015.02.6098","type":"journal-article","created":{"date-parts":[[2015,3,17]],"date-time":"2015-03-17T18:41:16Z","timestamp":1426617676000},"page":"e6098-e6098","source":"Crossref","is-referenced-by-count":1,"title":["Retrospective study comparing low-dose versus standard dose of bortezomib in patients with multiple myeloma"],"prefix":"10.5867","volume":"15","author":[{"given":"Marcela Espinoza","family":"Zelada","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole Befferman","family":"Cordova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mauricio Ocqueteau","family":"Tachini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pablo Ram\u00edrez","family":"Villanueva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mauricio Galleguillos","family":"M.","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mauricio Sarmiento","family":"Maldonado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3888","published-online":{"date-parts":[[2015,3,17]]},"reference":[{"issue":"2","key":"ref0","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1056\/NEJM199607113350204","article-title":"A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Fran\u00e7ais du My\u00e9lome.","volume":"335","author":"Attal","year":"1996","unstructured":"Attal M, Harousseau JL, Stoppa AM, Sotto JJ, Fuzibet JG, Rossi JF, et al. A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Fran\u00e7ais du My\u00e9lome. N Engl J Med. 1996 Jul 11;335(2):91-7. | CrossRef | PubMed |","journal-title":"N Engl J Med","ISSN":"http:\/\/id.crossref.org\/issn\/0028-4793","issn-type":"print"},{"issue":"1","key":"ref1","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/2050-7771-1-13","article-title":"The resistance mechanisms of proteasome inhibitor bortezomib.","volume":"1","author":"L\u00fc","year":"2013","unstructured":"L\u00fc S, Wang J. The resistance mechanisms of proteasome inhibitor bortezomib. Biomark Res. 2013 Mar 1;1(1):13. | CrossRef | PubMed |","journal-title":"Biomark Res","ISSN":"http:\/\/id.crossref.org\/issn\/2050-7771","issn-type":"print"},{"issue":"19","key":"ref2","doi-asserted-by":"publisher","first-page":"4375","DOI":"10.1182\/blood-2011-11-395749","article-title":"Randomized, multicenter, phase 2 study (EVOLUTION) of combinations of bortezomib, dexamethasone, cyclophosphamide, and lenalidomide in previously untreated multiple myeloma.","volume":"119","author":"Orlowski","year":"2012","unstructured":"Orlowski RZ, Stinchcombe TE, Mitchell BS, Shea TC, Baldwin AS, Stahl S, et al. Phase I trial of the proteasome inhibitor PS-341 in patients with refractory hematologic malignancies. J Clin Oncol. 2002 Nov 15;20(22):4420-7. | CrossRef | PubMed | Kumar S, Flinn I, Richardson PG, Hari P, Callander N, Noga SJ, et al. Randomized, multicenter, phase 2 study (EVOLUTION) of combinations of bortezomib, dexamethasone, cyclophosphamide, and lenalidomide in previously untreated multiple myeloma. Blood. 2012 May 10;119(19):4375-82. | CrossRef | PubMed |","journal-title":"Blood","ISSN":"http:\/\/id.crossref.org\/issn\/0006-4971","issn-type":"print"},{"issue":"26","key":"ref3","first-page":"1829","article-title":"Administration of bortezomib before and after autologous stem cell transplantation improves outcome in multiple myeloma patients with deletion 17p. Blood. 2012 Jan 26;119(4):940-8. | CrossRef | PubMed | Bao L, Lu XJ, Zhang XH, Huang XJ.","volume":"88","author":"Rosi-ol","year":"2008","unstructured":"Rosi-ol L, Oriol A, Mateos MV, Sureda A, Garc\u00eda-S\u00e1nchez P, Guti\u00e9rrez N, et al. Phase II PETHEMA trial of alternating bortezomib and dexamethasone as induction regimen before autologous stem-cell transplantation in younger patients with multiple myeloma: efficacy and clinical implications of tumor response kinetics. J Clin Oncol. 2007 Oct 1;25(28):4452-8. | CrossRef | PubMed | Neben K, Lokhorst HM, Jauch A, Bertsch U, Hielscher T, van der Holt B, et al. Administration of bortezomib before and after autologous stem cell transplantation improves outcome in multiple myeloma patients with deletion 17p. Blood. 2012 Jan 26;119(4):940-8. | CrossRef | PubMed | Bao L, Lu XJ, Zhang XH, Huang XJ. [Effects of bortezomib at different doses in combination with dexamethasone in treatment of relapsed or refractory multiple myeloma: a comparative study]. Zhonghua Yi Xue Za Zhi. 2008 Jul 8;88(26):1829-31. | PubMed |","journal-title":"Zhonghua Yi Xue Za Zhi","ISSN":"http:\/\/id.crossref.org\/issn\/0376-2491","issn-type":"print"}],"container-title":["Medwave"],"original-title":["Estudio retrospectivo que compara dosis bajas versus dosis est\u00e1ndar de bortezomib en pacientes con mieloma m\u00faltiple"],"link":[{"URL":"https:\/\/www.medwave.cl\/link.cgi\/Medwave\/Estudios\/Investigacion\/6098","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,11]],"date-time":"2019-07-11T11:55:52Z","timestamp":1562846152000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.medwave.cl\/link.cgi\/Medwave\/Estudios\/Investigacion\/6098.act"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3,17]]},"references-count":4,"journal-issue":{"issue":"02","published-online":{"date-parts":[[2015,3,17]]}},"URL":"https:\/\/doi.org\/10.5867\/medwave.2015.02.6098","relation":{},"ISSN":["0717-6384"],"issn-type":[{"value":"0717-6384","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,17]]}}}